BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17938921)

  • 1. Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.
    Alkhawaldeh K; Bural G; Kumar R; Alavi A
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):246-52. PubMed ID: 17938921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
    Macdonald K; Searle J; Lyburn I
    Clin Radiol; 2011 Mar; 66(3):244-50. PubMed ID: 21295203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
    Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S
    Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
    Conrad GR; Sinha P
    Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
    Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
    Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
    Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
    Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.
    Xiu Y; Bhutani C; Dhurairaj T; Yu JQ; Dadparvar S; Reddy S; Kumar R; Yang H; Alavi A; Zhuang H
    Clin Nucl Med; 2007 Feb; 32(2):101-5. PubMed ID: 17242561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
    Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
    Matthies A; Hickeson M; Cuchiara A; Alavi A
    J Nucl Med; 2002 Jul; 43(7):871-5. PubMed ID: 12097455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
    Schillaci O; Travascio L; Bolacchi F; Calabria F; Bruni C; Cicciò C; Guazzaroni M; Orlacchio A; Simonetti G
    Radiol Med; 2009 Sep; 114(6):890-906. PubMed ID: 19579015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.
    Zhao L; Tong L; Lin J; Tang K; Zheng S; Li W; Cheng D; Yin W; Zheng X
    Eur Radiol; 2015 Jul; 25(7):1837-44. PubMed ID: 25636419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
    Dabrowska M; Krenke R; Korczynski P; Maskey-Warzechowska M; Zukowska M; Kunikowska J; Orłowski T; Chazan R
    Medicine (Baltimore); 2015 Apr; 94(15):e666. PubMed ID: 25881842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease.
    Huang YE; Lu HI; Liu FY; Huang YJ; Lin MC; Chen CF; Wang PW
    J Radiat Res; 2012; 53(2):306-12. PubMed ID: 22374400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
    Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.
    Cloran FJ; Banks KP; Song WS; Kim Y; Bradley YC
    Lung Cancer; 2010 Apr; 68(1):66-71. PubMed ID: 19559496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.
    Grgic A; Yüksel Y; Gröschel A; Schäfers HJ; Sybrecht GW; Kirsch CM; Hellwig D
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1087-94. PubMed ID: 20140611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.